GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured and is focused on saving lives and improving health by pioneering new technologies for early cancer detection. Their first product, the Galleri® multi-cancer early detection test, complements guideline-recommended screenings, and can detect a cancer signal across more than 50 types of cancer through a routine blood draw for adults with elevated risk, such as aged 50 or older. For more information visit Booth #551 or Galleri.com.